Back to search
FDAFDA · Food and drugs·Recall number D-0292-2026

Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15

Published January 14, 2026 · Recall initiated: December 31, 2025

Summary

FDA records drug Class II recall D-0292-2026, published January 14, 2026 and initiated December 31, 2025. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 7,991 5x10 cartons; Lot: Lot #49124, Exp Date 12/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Out of specification for dissolution.

What to do

Voluntary: Firm initiated · Letter

Get an email if ROSUVASTATIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ROSUVASTATIN
Manufacturer
AvKARE
Distributor
Nationwide in the USA
Lot
Lot #49124, Exp Date 12/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15 recalled?

Yes. FDA published recall D-0292-2026 on January 14, 2026. Reported hazard: Out of specification for dissolution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ROSUVASTATIN.